A slew of digital diabetes care companies have announced integrations with the upcoming virtual Type 2 diabetes management platform being developed by , a joint venture of Verily and Sanofi. These announced services include ’ Insulia, a digital insulin dose recommendation and coaching system; ’s Glucommander Outpatient, cloud-based software that evaluates blood glucose and patient attribute to adjust insulin dosages; and ’s Telcare cellular-enabled glucometer and cloud-based data system.
“I believe Onduo’s program will have a tremendous impact on the lives of the millions of people living with diabetes,” Joseph H. Capper, president and CEO of BioTelemetry, said in a press release. “We are pleased to be able to support Onduo’s innovative approach to diabetes and to be working with such a dedicated group of individuals.”
Onduo’s offering seeks to bring Type 2 diabetes hardware and software tools together into a single platform accessible through a smartphone. Along with personalized care and daily support, Onduo’s platform looks to keep diabetes patients in with practitioners by assigning each user a personal care lead, who helps develop a care plan and works to keep patients on track between doctor visits.
Onduo was founded last year following a $500 million investment by Sanofi and Verily. At the time, Onduo said they would be working with Sutter Health of Northern California and Allegheny Health Network of western Pennsylvania to test the platform in a clinical care setting.
“From monitoring food intake to testing glucose levels to actively seeking medical care, the challenges both on the physical and mental well-being of a person living with diabetes are incredibly difficult,” Onduo CEO Dr. Joshua Riff said when the joint venture was founded. “We want to develop solutions that allow people living with diabetes to focus on the things they love and enjoy life by providing tools to make dealing with their diabetes less burdensome.”
According to statements from Voluntis and Glytec, the new integrations will launch in pilot programs among certain US providers and payers through the beginning of 2018.
“We are very excited to partner with Onduo and play an important role in this integrated care solution,” Glytec President and CEO Bob Leonard said in a statement. “We firmly believe that this type of best-of-breed matrix approach — synthesizing the most essential and innovative technologies and services — will emerge as the most potent way to drive improvements in the quality, safety and cost of care for people living with diabetes.”
While the pilot programs’ participating organizations weren’t detailed, it wouldn’t be a stretch to count the Blue Cross Blue Shield Association (BCBSA) among them due to its of an Onduo partnership and pilot, also scheduled for early 2018. The program, according to the insurance group, will be measuring clinical, cost, and member experience outcomes among members living in Arkansas, Georgia, and South Carolina.
"Blue Cross and Blue Shield companies have a long history of bringing locally tailored, innovative programs to the communities we serve," Jody Voss, vice president of development, innovation, and the group purchasing organization for BCBSA, said in a statement. "We are pleased to be able to continue this tradition by partnering with Onduo on a new diabetes management program that will help eligible members better manage their type 2 diabetes."